Literature DB >> 12038151

Partial antagonism of tiletamine-zolazepam anesthesia in cheetah.

C Walzer1, C Huber.   

Abstract

This study evaluated partial antagonism of tiletamine-zolazepam (TZ) anesthesia in cheetahs (Acinonyx jubatus) and differences between two benzodiazepine antagonists, flumazenil and sarmazenil, in this species. Four cheetahs were anesthetized three times at an interval of 14 days with an average intramuscular dose of 4.2 mg/kg TZ. In trials 2 and 3 flumazenil at 0.031 mg/kg and sarmazenil at 0.1 mg/kg, respectively, were applied intramuscularly 30 min after initial TZ injection. There was a highly significant difference between the duration of TZ anesthesia with and without antagonist. Use of the antagonists significantly shortened duration and recovery and eliminated excitatory behavior during the recovery phase. No significant differences could be determined between the two antagonists. We recommend the use of sarmazenil and flumazenil to antagonize TZ anesthesia in cheetahs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12038151     DOI: 10.7589/0090-3558-38.2.468

Source DB:  PubMed          Journal:  J Wildl Dis        ISSN: 0090-3558            Impact factor:   1.535


  2 in total

1.  Use of brachial plexus blockade and medetomidine-ketamine-isoflurane anaesthesia for repair of radio-ulna fracture in an adult cheetah (Acinonyx jubatus).

Authors:  Peter Kimeli; Eddy M Mogoa; Willy E Mwangi; Ambrose N Kipyegon; Gilbert Kirui; Daniel W Muasya; John D Mande; Edward Kariuki; Dominic Mijele
Journal:  BMC Vet Res       Date:  2014-10-10       Impact factor: 2.741

2.  Chemical immobilization of free-ranging and captive Sunda clouded leopards (Neofelis diardi) with two anesthetic protocols: medetomidine-ketamine and tiletamine-zolazepam.

Authors:  Fernando Nájera; Andrew J Hearn; Joanna Ross; Diana A Ramírez Saldivar; Meaghan N Evans; Sergio Guerrero-Sánchez; Senthilvel K S S Nathan; Ignacio DE Gaspar Simón; David W Macdonald; Benoit Goossens; Luis Revuelta Rueda
Journal:  J Vet Med Sci       Date:  2017-09-14       Impact factor: 1.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.